Congress quietly exempts premium cigars from FDA health oversight
S. 3922 — Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026 · Filed by Ashley Moody (R-FL) · 1 cosponsor · Introduced Feb 25, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill exempts 'traditional large and premium cigars'—defined as hand-rolled or semi-hand-rolled cigars made entirely from leaf tobacco, weighing at least 6 pounds per 1,000 count—from FDA regulation under the Federal Food, Drug, and Cosmetic Act. The exemption removes FDA authority to regulate these cigars' manufacturing, marketing, or composition, while keeping other tobacco products (cigarettes, little cigars) under FDA oversight.
Why we flagged it
The bill's core function is to exempt a specific tobacco product category from federal health and safety regulation. Despite the title's emphasis on 'small business' and 'jobs,' the mechanism is a narrow regulatory exemption that benefits cigar manufacturers and importers while reducing public-health oversight.
What the text implies
- FDA loses ability to monitor or regulate marketing claims, ingredient disclosures, or health warnings for exempted cigars, creating a regulatory blind spot for a nicotine product.
- The definition's specificity (6 lbs per 1,000 count, hand-rolled or semi-hand-rolled) may be narrowly tailored to protect a particular manufacturer or import category, though the text does not name beneficiaries.
The full analysis lists 5 implications of this text.
Who stands to gain
premium cigar manufacturers; cigar importers; hand-rolled cigar producers